In recent times, non-economic shocks -- whether they are due to intensifying trade disputes like the US-China trade war, political upheavals like Brexit or high cost natural disasters like Hurricane IRMA in USA or the earthquake-cum-tsunami in Japan - have raised the questions on contract enforcement.
Now, the novel coronavirus, or COVID 19, pandemic has once again brought to focus on what corporates should do amidst this mayhem. While this is by no means an exhaustive list, it tries to put forth a few areas which corporates need to concentrate on.General | A few items for consideration may include:
- Assess whether COVID-19 will affect the company’s ability to meet its outstanding obligations – on account of a direct impact or outside supplier -- and draw contingency plans
Insurance: Analyse in totality all insurance policies to ensure the company is covered for damages resulting from the pandemic. Examine property & casualty (P&C), business interruption, business income, employees, general liability, director & officer (D&O) liability, cyber security and specific disease related policies.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Carefully review material adverse change clause to include COVID-19, adequacy of warranties and indemnities, standstill obligations and long stop date wherever applicable.Supply chain
Review commodity or index linked contractsFinancial systemExamine all financing documents to assess how COVID-19 will impact your ability to sustain your business currently and in future. Prepare for potential effects on interest rates, borrowing costs, property and asset values, contract modification for additional funding needs, amending terms of existing loan agreements or seeking waivers if unable to satisfy loan covenants. Proactively communicate with lenders and investors
Litigation: Proactively seek extension of deadlines
Employees: Place signages in all common areas to maintain hygiene - encourage stay and work from home - issue guidelines for employees returning from abroad. Above all, be lenient in paying salaries and emphasise prevention and control of spreading the virus
Cyber security: With employers and governments insisting on work from home it has become harder to:
- Maintain security and business continuity
- Maintaining confidentiality, integrity and availability of consumer facing networks as volumes spike. Information technology and legal will have to work together to safeguard their organisations
Future contracts: Recognising that there is only that much one can do in case of existing contracts except following a collaborative approach to renegotiate the clauses, it is necessary to review the following clauses in future contracts in the light of the pandemic: force majeure, client responsibility to secure their own travel insurance, inclement weather policies, cancellation and rescheduling, safe working environment, indemnification clause, limitation of liability, failure of company to perform services, etc
Onerous contracts: Recognise onerous contracts, lease agreements and ongoing and future revenue contracts.PK Ghose is former Executive Director and CFO of Tata Chemicals and now a member of the CFO Board. The views expressed are personal